Clinical and genomic characterization of metastatic small cell/neuroendocrine prostate cancer (SCNC) and intermediate atypical prostate cancer (IAC): Results from the SU2C/PCF/AACRWest Coast Prostate Cancer Dream Team (WCDT).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 5019-5019 ◽  
Author(s):  
Eric Jay Small ◽  
Rahul Raj Aggarwal ◽  
Jiaoti Huang ◽  
Artem Sokolov ◽  
Li Zhang ◽  
...  
2021 ◽  
Author(s):  
Shubhangi Agarwal ◽  
donna.peehl not provided ◽  
Renuka Sriram

This protocol describes the steps required for the successful implantation of small cell neuroendocrine prostate cancer patient-derived xenograft (PDX) cells in the bone. Bone is one of the most common sites for the development of metastatic prostate cancer and its study is important for evaluating the tumor characteristics and response to therapy. This protocol can be used for the implantation of any tumor cell line in the bone.


2018 ◽  
Vol 149 ◽  
pp. 187
Author(s):  
R.N. Eskander ◽  
J.A. Elvin ◽  
L.M. Charo ◽  
P. Mayor ◽  
M.T. McHale ◽  
...  

2019 ◽  
Author(s):  
Shoujie Chai ◽  
Paymaneh D. Malihi ◽  
Ana M. Apariciop ◽  
Brian F. Chapin ◽  
Matthew Lin ◽  
...  

2019 ◽  
Vol 26 (7) ◽  
pp. 1667-1677 ◽  
Author(s):  
Alexandra N. Corella ◽  
Ma Victoria Andrea Cabiliza Ordonio ◽  
Ilsa Coleman ◽  
Jared M. Lucas ◽  
Arja Kaipainen ◽  
...  

2015 ◽  
Vol 22 (6) ◽  
pp. 1510-1519 ◽  
Author(s):  
Himisha Beltran ◽  
Adam Jendrisak ◽  
Mark Landers ◽  
Juan Miguel Mosquera ◽  
Myriam Kossai ◽  
...  

2011 ◽  
Vol 1 (6) ◽  
pp. 487-495 ◽  
Author(s):  
Himisha Beltran ◽  
David S. Rickman ◽  
Kyung Park ◽  
Sung Suk Chae ◽  
Andrea Sboner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document